Vitamin D and Calcium Supplement Attenuate Bone Loss Among HIV- Infected Patients Receiving Tenofovir Disoproxil Fumarate, Lamivudine or Emtricitabine and Efavirenz
Clinical trial NCT02827643 · UNKNOWN
Trial details
- NCT number
- NCT02827643
- Sponsor
- Mahidol University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.